Casdin Capital’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-70,638
| Closed | -$39.6M | – | 51 |
|
2020
Q4 | $39.6M | Hold |
70,638
| – | – | 1.17% | 22 |
|
2020
Q3 | $49.4M | Sell |
70,638
-14,668
| -17% | -$10.3M | 2.21% | 13 |
|
2020
Q2 | $67.4M | Hold |
85,306
| – | – | 3.99% | 8 |
|
2020
Q1 | $50.8M | Buy |
85,306
+10,422
| +14% | +$6.2M | 5.39% | 6 |
|
2019
Q4 | $85.1M | Buy |
74,884
+27,599
| +58% | +$31.4M | 7.83% | 2 |
|
2019
Q3 | $56.2M | Buy |
47,285
+18,528
| +64% | +$22M | 5.82% | 7 |
|
2019
Q2 | $47.4M | Buy |
28,757
+1,158
| +4% | +$1.91M | 4.43% | 9 |
|
2019
Q1 | $56.2M | Buy |
27,599
+2,123
| +8% | +$4.33M | 6.18% | 5 |
|
2018
Q4 | $32.7M | Buy |
25,476
+5,558
| +28% | +$7.14M | 5.6% | 6 |
|
2018
Q3 | $37.7M | Buy |
19,918
+4,478
| +29% | +$8.47M | 4.58% | 9 |
|
2018
Q2 | $31.4M | Buy |
15,440
+4,246
| +38% | +$8.63M | 4.39% | 7 |
|
2018
Q1 | $24.8M | Hold |
11,194
| – | – | 4.35% | 12 |
|
2017
Q4 | $25.8M | Hold |
11,194
| – | – | 6.29% | 5 |
|
2017
Q3 | $19.9M | Buy |
11,194
+6,176
| +123% | +$11M | 5.62% | 6 |
|
2017
Q2 | $6.83M | Buy |
5,018
+3,049
| +155% | +$4.15M | 2.53% | 15 |
|
2017
Q1 | $2.32M | Sell |
1,969
-4,400
| -69% | -$5.18M | 1.37% | 26 |
|
2016
Q4 | $5.09M | Buy |
6,369
+1,737
| +38% | +$1.39M | 4.2% | 9 |
|
2016
Q3 | $4.07M | Sell |
4,632
-4,825
| -51% | -$4.24M | 3.29% | 11 |
|
2016
Q2 | $5.3M | Buy |
9,457
+193
| +2% | +$108K | 5.28% | 8 |
|
2016
Q1 | $5.1M | Buy |
9,264
+1,544
| +20% | +$850K | 5.85% | 8 |
|
2015
Q4 | $6.42M | Buy |
+7,720
| New | +$6.42M | 5.67% | 6 |
|